Abstract
It is shown in the paper that implantation in rats of a 5 mg synestrol tablet (equivalent to an average therapeutic dose of the preparation used in treating milk-duct carcinoma in man) eliminates or reduces the growth hormone's capacity of raising the level of free fatty acids in blood serum. The paper discusses at some length the importance of this antagonism phenomenon necessitating a more profound study which would include the development of acromegaloid features with aging, as well as investigating the issues arising from the antagonism to other properties of the growth hormone, the studies involving the use of both the estrogens and the hypophyseal inhibitors.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
